Price $0.61 |
Market Cap
17.5M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
2.21
|
P/S
14.48
|
Dividend %
-
|
|
P/CF
19.1
|
P/FCF
-
|
Op. Cash Flow
-1.9K
|
FCF
0.0
|
|
Op. Margin
-153.30%
|
Net Margin
-172.10%
|
ROE
-29.00%
|
ROI
-20.70%
|
|
ROA
-18.70%
|
EPS Growth
43.10%
|
Current Ratio
2.8
|
Debt/Equity
35.10%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Reliv International, Inc (RELV) | $4.70 | - | - | 8.3M | Strong Buy |
| China Pharma Holdings, Inc. (CPHI) | $0.28 | - | - | 13.1M | Strong Buy |
| Premier Inc (PINC) | $32.41 | - | - | 4.5B | Strong Buy |
| Chembio Diagnostics Inc (CEMI) | $8.75 | - | - | 111.9M | Strong Buy |
| Impax Laboratories Inc (IPXL) | $18.30 | - | - | 1.42B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
